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Abstract
Platelet-rich plasma is a therapeutic strategy used for accelerating wound healing of a wide range of tissues through the release of platelet growth factors.
Here, we describe a nonchemical, safe method for preparing platelet-rich
plasma using nanosecond-pulsed electric fields (nsPEFs) and investigated the
effect of this platelet-rich plasma on reperfusion of blood in large skin flap or
ischemic hind limb wounds in New Zealand White rabbits. Laser Doppler
images of blood flow to the dorsal surface of skin flap wounds or to ischemic
hind limb wounds were obtained from wounds treated with 0.9% saline or
nanosecond-pulsed electric field prepared platelet-rich plasma (nsPRP). Reperfusion in the skin flap wounds was greater in the nsPRP-treated wounds than
in the wounds treated with saline on postoperative days 3 (P < 0.001) and 21
(P < 0.03). Reperfusion in the ischemic hind-limb treated with nsPRP was
greater than in the saline-treated limb on post-operative Day 3 (P < 0.001),
post-operative week 1 (P < 0.025) and post-operative week 4 (P < 0.015). In
the hind limb ischemic tissue, the number of endothelial cells, collagen, and
cells containing vascular endothelial growth factor (VEGF) was greater in the
nsPRP-treated tissue. These results demonstrate that nsPRP improves blood
flow in large surgical skin wounds and in ischemic wounds.
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Introduction
Platelet-Rich Plasma (PRP) is a platelet-rich concentrate
which is activated to release growth factors that strongly
influence wound healing. Degranulation of the alpha
granules in platelets deposits a concentrated amount of
proteins, including growth factors, chemokines, and cytokines, onto the wound that are known to play a role in
enhancing healing (Knighton et al. 1986, 1988; Everts
et al. 2006). PRP is produced autologously to prevent

host versus graft complications. Platelet-rich plasma is
emerging as an alternative treatment or as a treatment in
combination with other therapeutic methods that are
both safe and more cost-effective than many of the presently used wound healing treatments.
The standard clinical platelet activator is bovine thrombin. Though effective, many of the principal actions of
thrombin may be harmful to some patients. Thrombin is
proapoptotic and proinflammatory, both induced by the
generation of reactive oxygen species (ROS) (Lopez et al.
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2007; Raivo et al. 2009). There is evidence to show that
bovine thrombin interferes with the efficacy of PRP. PRP
has the potential to increase the osteo-inductivity of
demineralized bone matrix. However, its activation with
bovine thrombin immediately prior to implantation significantly inhibits this activity (Margolis et al. 2001). To
overcome the problems associated with exposing the
patient to thrombin-activated PRP, we alternatively activated platelets by exposing them to nanosecond-pulsed
electric fields (nsPEF) (Schoenbach et al. 2007; Zhang
et al. 2008). These ultrashort, intense electrical pulses
activate the platelets and create microscopic pores in the
platelet membranes through which growth factors, cytokines, chemokines, and other proteins may permeate. In
this way, we obtain a nonchemically activated PRP,
nsPEF-activated PRP (nsPRP), which does not pose the
systemic risk of an allergic reaction and other untoward
effects associated with chemical activators, such as thrombin. We have reported that nsPRP reduces ROS production in vitro and improves left ventricular heart function
after myocardial infarction (Hargrave and Li 2012).In
addition, we have reported that in the Langendorff rabbit
heart model left ventricular function is improved in globally ischemic/reperfused hearts treated with nsPRP
(Hargrave 2014).
Recombinant human platelet-derived growth factor-BB
isomer (rh-PDGF-BB) has also been used to enhance
wound healing (Marx 2001). While growth factors such
as rh-PDGF-BB is of human origin, it is foreign to the
patient being treated and may be antigenic. The autologous nature of PRP makes it more akin to the natural
healing process, and exposes the wound to multiple
growth factors all of which may play a role either directly
or indirectly in enhancing wound healing.
One hallmark of successfully healing a wound is a significant return of blood flow to the injured site (Zografos
et al. 1992). In this study, we investigated the effect of
nsPRP on the return of blood flow to the wounded site
in two different wound models. One wound was a large
surgical wound created on the dorsal surface of the New
Zealand White (NZW) Rabbit. The second wound was an
ischemic wound created in the right hind limb of the
NZW rabbit. The focus of this study is to show that
nsPRP is effective in enhancing the return of blood flow
to the wound.

Hargrave & Li

approved by the Old Dominion University’s animal care
and use committee.

Nanosecond pulse electric field (nsPEF) and
the pulse generator
Nanosecond pulse electric fields are ultrashort, high-voltage-pulsed electric fields that effect intracellular as well as
extracellular membranous structures and functions
(Schoenbach et al. 2007). Nanosecond pulses convey
intense, high power, but low-energy electric fields. During
platelet activation, nsPEFs charge the platelet membrane
and create pores without inducing permanent damage
(Schoenbach et al. 2007; Zhang et al. 2008). The 300 ns
pulse generator used for these studies has been previously
described (Schoenbach et al. 2007; Zhang et al. 2008).
The electrical pulses were applied to PRP in sterile aluminum electroporation cuvettes having an electrode gap of
0.4 cm and an area of 1 cm2. The shape and amplitude
of the pulse voltage was monitored using a 500 MHz
oscilloscope. For the generation of PRP, one milliliter of
PRP in the presence of 10 mM CaCl2 was exposed to five
pulses at an electric field of 30 kV/cm.

Preparation of platelet rich plasma (PRP)
Hematological analysis of rabbit blood used to prepare
nsPRP was performed using a HESKA Diagnostic System,
Switzerland. The PRP had an average platelet count of
295 9 103/lL. The Harvest Technology System concentrator (Harvest Technologies, Plymouth, MA) concentrated the platelets in the whole blood 4–7 times
providing a platelet concentrate between 1180 9 103/lL
and 2065 9 103/lL of platelets.
PRP was prepared per the Harvest Technologies protocol. Briefly, 60 mL of blood was withdrawn from a donor
rabbit using a sterile syringe containing 6 mL of ACD-A
anticoagulant. A SmartPRep-2 Platelet Concentrate System and a sterile processing disposable pack (Terumo Cardiovascular Systems, Ann Arbor, MI) was used to prepare
PRP. The processing disposable was centrifuged for 14 min
to separate the blood components from the plasma. PRP
was prepared by resuspending the platelet concentrate with
platelet poor plasma to a final volume of 7 mL.

Preparation of nsPRP Supernatant

Materials and Methods
We used a total of 38 animals in this study. The use of
animals in this study was conducted in an AAALAC
accredited facility and in compliance with the animal welfare act and other federal statutes and regulations pertaining to animals. All procedures outlined in this study were
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Platelets were concentrated as described above. For the
generation of PRP, one milliliter of PRP in the presence
of 10 mM CaCl2 was exposed to five pulses at an electric
field of 30 kV/cm. To prepare a PRP supernatant the
nsPRP was removed from the cuvette and placed into a
sterile 1 mL Eppendorff tube for 10 min at room temper-
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ature. The Eppendorff tube was then centrifuged at
14,000 rpms for 10 min. The supernatant was removed
and placed into an Alzet Osmotic Pump (Durect Corporation, Cupertino, CA) prior to insertion of the pump
into the wound. The remaining pellet was discarded.

Measurement of blood flow to the wound
using a laser Doppler imager
A Moor Laser Doppler Imager (LDI) (Moor Instruments,
Wilmington, DE) was used to measure the total local microcirculatory blood perfusion on the dorsal surface of the
skin flap wound and in the hind limb ischemic wounds.
The technique is based on the emission of a beam of laser
light carried by a fiber-optic probe. The light is then scattered and partly absorbed by the tissue being studied.
Light hitting moving blood cells undergoes a change in
wavelength (Doppler shift) while light hitting static objects
is unchanged. The skin flap wound area of the rabbit was
imaged using the LDI prior to surgery at Day 0, immediately after surgery, and on postoperative days 2, 7, and 14.
For quantitative analysis, the surgical area was integrated
to create a region of interest (ROI). The 3 9 8 cm surgically created skin flap wound was arbitrarily divided into a
distal, medial and proximal segments for analysis. We
report data from all three segments of the wound. A statistical table associated with the ROI was generated by the
imaging software (Moor Instruments, Wilmington, DE).
The unit of measurement is an arbitrary perfusion unit.
Day 0 prior to the surgery was used as a baseline for each
animal. In addition, Day 0 after the surgery was used as
postoperative baseline for each animal. The percentage of
pre-surgery baseline and percentage of postoperative baseline were used for evaluation.

Surgical wound created on the dorsal
surface of the New Zealand white rabbit
New Zealand White Rabbits (Harlan, Inc, Frederick,
Maryland) were sedated with a combination of xylaine
(5 mg/kg) and ketamine (25 mg/kg) delivered intramuscularly. General anesthesia was induced using isoflurane
in oxygen (5 L/min for 1 min then 1.5 L/min for the
duration of the procedure). The dorsal surface was shaved
and cleansed with 70% ethanol and chlorhex-Q scrub.
Once a surgical plane of anesthesia was established, a
3 9 8 cm skin flap wound was created on the dorsal surface of the animal. NsPRP or 0.9% saline in a volume of
1 mL was placed on the wound and the flap sutured to
its original position, using 4–0 silk interrupted stitches.
We focused our analysis on the distal segment of the
wound since this segment had the greatest degree of
blood flow disruption.

Creation of the ischemic hind-limb wound
New Zealand White Rabbits (Harlan, Inc, Frederick, Maryland) were sedated with a combination of xylazine (2 mg/
kg) and ketamine (25 mg/kg) delivered intramuscularly.
General anesthesia was induced using isoflurane in oxygen
(5 L/min for 1 min then 1.5 L/min for the duration of the
procedure). To investigate the effect of nsPEF-activated
PRP on wound healing in the presence of ischemia, an
incision was made on the medial thigh of the right hind
limb. Ischemia was created by the removal of a 2 cm segment of the femoral artery. This was viewed as the
“wound” to that limb. In this study, we delivered nsPRP
supernatant continuously to the wound. An Alzet Osmotic
pump (Durect Corporation, Cupertino, CA) measuring
3 9 0.7 cm, was placed subcutaneously in the right thigh
of the hind limb parallel to the ischemic region of the
wound. The flow rate of the pump was 0.25 lL/h. The
pump was filled with 250 lL of either PRP supernatant or
saline with a duration of release of 28 days. In this study,
we measured blood flow in the wound area on day 0
before and after surgery, followed by postoperative days 3,
7, 14, 21, and 28 using Laser Doppler Imaging.

Immunohistochemistry
Wound tissue was placed in 10% formalin and sent to an
outside vendor for paraffin embedding and processing.
Slides containing tissue from the area of interest of the
hind-limb ischemic wound were processed as follows:
washed in xylene twice, once in 100%, 95%, 0%, and
50% ethanol for 1 min each, then washed in deionized
water for 5 min. Three percent hydrogen peroxide was
added to each slide, and incubated at room temperature
for 10 min then washed again. For antigen retrieval,
150 mL of a citrate buffer was prepared and placed into a
container containing the slides in a tissue rack. The container was placed heated in the microwave for 3 min 4
times. The primary antibodies: anti-collagen, VEGF, and
CD-31 were used at a dilution of 1:100 (Abcam, Cambridge, MA). The secondary antibody- TRITC red rhodamine (ThermoFisher Scientific, Grand Island, NY) was
used at a dilution of 1:125. The SlowFade Gold AntiFade
reagent with DAPI (Molecular Probes, Grand Island, NY)
was used as a nuclear stain.

Statistical analysis
The Laser Doppler Imager data were analyzed using an
analysis of variance corrected for repeated measures and
stated as the mean  standard deviation. The Tukey and
Student-Newman–Keuls post hoc tests were used to determine which groups were statistically different from each
other. Where applicable, data are stated as the mean  SD.

ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.

2015 | Vol. 3 | Iss. 7 | e12461
Page 3

Nanosecond-pulsed electric field prepared platelet-rich plasma and the ischemic skin wound

Results
3 3 8 cm skin flap wound
Seventeen animals were studied. Figure 1, panels A–H
show a representative Laser Doppler Image of blood flow

A

Proximal
Segment
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and its return in the skin flap wounds treated with 0.9%
saline or nsPRP.
Figures 2 A–C show the quantitative analysis of blood
flow in the distal, medial, and proximal segments of the
3 9 8 skin flap wound. Reperfusion was significantly
greater in the nsPRP-treated wounds than in the wounds

E

Medial
Segment

Distal
Segment

B

F

C

G

D

H

Figure 1. Representative Laser Doppler image of blood flow and its return to the dorsal surface of skin flap wounds treated with 0.9% saline
(A through D) or nsPRP (E through H). The blue color within the 3 X 8 wound area is indicative of a lack of blood flow. The red color indicates
the presence of blood flow.
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A
Mean,
% Postoperative perfusion units
(arbitrary units)

Blood flow to distal region of the skin flap wound
treated with nsPRP or saline
450
400
350
300
250
200
150
100
50
0

* p<0.09

p<0.06

* p<0.09
*p< 0.04

Hind limb ischemic wound
0

3

7

14

21

nsPRP Treated, n = 10

0

248

313

277

281

Saline control, n = 7

0

159

255

208

150

Blood flow to medial region of the skin flap wound
treated with nsPRP or saline
Mean,
% Postoperative perfusion units
(arbitrary units)

B

600
500

p<0.07

p<0.06

400
300
200
100
0

0

3

7

14

21

nsPRP Treated, n = 10

0

240

295

257

270

Saline control, n = 7

0

174

238

200

169

C

These data suggest that the PRP prepared using nsPEFs
enhances the return of blood flow to the distal segment
of the skin flap wound in the NZW rabbit. It is the distal
segment of the wound that experiences the greatest degree
of blood disruption.

We studied 21 animals in this experiment. Figure 3, panels A–H show a representative Laser Doppler Image of
the return of blood flow in ischemic hind limb wounds
treated with 0.9% saline or nsPRP supernatant. Figure 4
shows the quantitative analysis of blood flow to the ischemic hind limb in wounds treated with nsPRP supernatant
(n = 10), or 0.9% saline (n = 11). The nsPRP supernatant
was prepared and the osmotic pump filled as previously
described. Reperfusion in the hind-limb treated with
nsPRP supernatant was significantly greater than in the
saline-treated limb on postoperative Day 3 (P < 0.001),
post-operative week 1 (P < 0.025), and postoperative
week 4 (P < 0.015). The data were normalized to 100%
of the postoperative perfusion. The results were the same
when we normalized the data to 100% of the preoperative
perfusion (data not shown).

Mean,
% Postoperative perfusion units
(arbitrary units)

Blood flow to the proximal region of the skin flap
wound treated with nsPRP or saline

Immunohistochemistry of Hind-limb Wound

300
250
200
150
100
50
0

0

3

7

14

21

nsPRP Treated, n = 10

0

190

212

166

171

Saline control, n = 7

0

194

187

145

159

Figure 2. Quantitative analysis of blood flow to the distal (A),
medial (B) and proximal (C) segments of the wound. The data were
normalized to 100% of postoperative perfusion. Data are stated as
mean  SD. nsPRP = nanosecond pulsed electric field activated
PRP; saline control = 0.9% saline; 0 = day of surgery; 3 = days
postoperative; 7 = days postoperative; 14 = days postoperative; 21
= days postoperative.

treated with a saline control on postoperative days 3
(P < 0.001) and 21 (P < 0.04). The data were normalized
to 100% of the postoperative perfusion. PRP prepared,
using nsPEFs significantly enhanced the return of blood
flow to the distal segment of the skin flap wound in the
NZW rabbit. The results were the same when we normalized the data to 100% of the preoperative perfusion (data
not shown).

We analyzed the ischemic hind-limb wounds for the presence of selected vascular markers. Table 1 summarizes the
number of cells per unit area staining positive for the various vascular markers in tissues treated with nsPRP or
saline.
To ascertain whether angiogenesis was associated with
the increase in blood flow in the nsPRP-treated wounds,
we used the vascular marker CD-31. This marker was
used to demonstrate the presence of endothelial cells in
tissue sections. Figure 5 shows that endothelial cells were
more prevalent in the nsPRP-treated wounds than in the
wounds treated with saline.
We also analyzed the tissue for changes in collagen
using a collagen marker (Fig. 6) and changes in VEGF
(Fig. 7). There was a greater degree of collagen and VEGF
in the ischemic limbs treated with nsPRP than in the
hind-limbs treated with saline.
Wounds treated with nsPRP stained positive for
markers indicative of angiogenesis and collagen synthesis
to a greater extent than the wounds treated with saline. It
should be noted, however, that the background appeared
greater in the saline micrograph, but not in the PRPtreated tissue and that there was greater nonspecific
staining. The rationale for this difference is unclear since
all slides were treated using the same protocol and
exposed to the same number of washes.
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Figure 3. Representative Laser Doppler images of blood flow and its return to the ischemic hind limb wounds treated with 0.9% saline
(A through D) or nsPRP (E through H). The blue color within the wound area is indicative of a lack of blood flow. The red color indicates the
presence of blood flow.

Discussion
The purpose of this study was to show nsPRP as an effective nonchemical agent in enhancing blood flow to
wounds. NsPRP is a safe and cost-efficient method to
treat wounds. There are several studies supporting the use
of PRP to enhance healing of wounds in general and difficult wounds in diabetic patients (Krupski et al. 1991;
Margolis et al. 2001; Cullinane et al. 2002; McAleer et al.
2006; Pietramaggiori et al. 2006; Salemi et al. 2008;
Gomez-Caro et al. 2011; Jl et al. 2012; Sakata et al. 2012
Apr; S€
onmez et al. 2013 Apr; Kontopodis et al. 2015). In
one study, PRP was reported to successfully heal a
chronic lower extremity wound after failed attempts at a
living skin graft application (Zografos et al. 1992). The
combination of adipose tissue and PRP was found by
some researchers to enhance graft adherence (Cullinane

2015 | Vol. 3 | Iss. 7 | e12461
Page 6

et al. 2002). In a respective cohort study estimating the
effectiveness of platelet foot ulcers, the researchers found
that the relative risk for a wound to heal after treatment
was 95% when compared to the standard of care
(Margolis et al. 2001). Another retrospective longitudinal
study by Sakata et al. reported good wound healing and a
low amputation rate in patients with diabetes mellitus and
ischemia treated with supportive care and PRP (Sakata
et al. 2012 Apr). On the other hand, there are also studies
that do not support the use of growth factor therapy.
Krupski et al. found that wounds treated with a wound
healing formula – a mixture of growth factors including
PDGF, PF4, TGF-b, PDEGF, and PDAF healed no better
than traditional therapy (Krupski et al. 1991). Lacci et al.
suggest that the presence of confounding variables in the
various patients may account for the discrepancy.
These variables include differences in diabetic patient
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Blood flow in the hind limb ischemic wound treated with nsPRP
900.0

***

800.0

**

Mean,
% Postoperative perfusion

700.0

600.0

500.0

*
400.0

300.0

200.0

100.0

0.0

0

3

7

14

21

28

PRP Treated

100.0

675.9

537.4

316.1

201.8

280.4

Saline control

100.0

434.8

356.6

231.3

160.6

146.5

Figure 4. Quantitative analysis of blood flow to the ischemic hind limb wound. The data were normalized to 100% of postoperative perfusion.
Data are stated as mean  SD. 0 = day of surgery; 3, 7, 14, 21 and 28 = days postoperative.

Table 1. Summary of the number of cells per unit area staining
positive for vascular markers or collagen

A

Cells/unit area staining positive

CD-31
VEGF
Collagen

nsPEF PRP (treated)

Saline (control)

17
30
27

2
0
0

characteristics, initial wound area, depth and duration
(Lacci and Dardik 2010). It is also possible that the
method used for platelet-rich plasma preparation and the
platelet count may vary, and therefore yield different
results.
We have shown in this study that when the platelet
count is relatively constant, and the platelets are concentrated to approximately the same degree (4–7 times baseline platelet count in whole blood) that (1) reperfusion in
nsPRP-treated wounds was significantly greater than in
the saline-treated wounds; and (2) nsPRP-treated wound
have markers present indicating angiogenesis. While the
ischemic hind-limb wound was continually exposed to

B

Figure 5. Immunohistochemical analysis of rabbit hind limb
ischemic tissue treated with 0.9% saline (A) or nsPRP (B). The
arrows indicate the presence of endothelial cells in the nsPRP
treated tissue.

nsPRP for 28 days via the Alzet Osmotic Pump is unclear
whether an infusion of nsPRP is required for it to be effectiveness versus a single intra-wound injection. In this
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A

B

Figure 6. Immunohistochemical analysis of rabbit hind limb
ischemic tissue treated with 0.9% saline (A) or nsPRP (B) and
stained for the presence of collagen. The arrows indicate cells in
the nsPRP treated tissue staining positive for collagen.

A

B

Figure 7. Immunohistochemical analysis of rabbit hind limb
ischemic tissue treated with 0.9% saline (A) or nsPRP (B) and
stained for the presence of vascular endothelial growth factor
(VEGF). The arrows indicate cells in the nsPRP treated tissue staining
positive for VEGF.

study, we elected to continually expose the ischemic hindlimb wound to nsPRP because of the severity of the
wound. However, the skin flap wounds received a onetime
treatment and blood flow was restored to these wounds to
a degree that was significantly greater than what was
observed in the control animals. The immunohistochemical data presented in this study was obtained from the
more severe ischemic hind limb wounds and showed that
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wounds treated with nsPRP had a greater presence of
endothelial cells, collagen and VEGF compared to tissue
treated with saline. These data suggest that there was
greater angiogenesis in the nsPRP-treated tissue and are
supported by the work of Sonmez et al. who concluded
from their studies that the angiogenic effects of PRP may
be potentiated by ischemia (S€
onmez et al. 2013 Apr).
We did not use bovine thrombin-activated platelets as
a control in this study since it was not our intention to
compare or study the effects of bovine thrombin. However, in subsequent experiments treating the infarcted tissue in the rabbit heart with PRP prepared using nsPEFs
or bovine thrombin the nsPRP was associated with
greater left ventricular function than hearts treated with
bovine thrombin PRP. This was not observed in the
hearts treated with vehicle (bovine serum albumin)
(Hargrave 2014). Also, we previously compared a plateletrich plasma supernatant prepared using bovine thrombin
to a platelet-rich plasma supernatant using nsPEF and
found that there was little or no endogenous antioxidants
(i.e., catalase and superoxide dismutase) in the thrombinactivated platelets compared to the nsPEF activated platelet-rich plasma (Hargrave 2014). This is consistent with
the report by Han et al. showing that PRP prepared using
bovine thrombin inhibited induction of osteo-inductivity
of demineralized bone matrix (Han et al. 2009).
NsPEF activation of platelets for the preparation of
platelet-rich plasma is both safe and effective. It is
nonchemical, so there are no adverse systemic effects that
tend to be associated with most chemical activators.
Using immunohistochemistry, we have shown that nsPRP
increased vascular and collagen markers that are designed
to produce vessel formation and collagen synthesis,
respectively, thereby providing a mechanism for the
enhanced blood flow observed in the PRP-treated
wounds. In summary, we investigated the effect of nsPRP
on large skin flap wound and on ischemic wounds, and
found nsPRP to be effective in enhancing blood flow to
the injured tissue.
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